[Form 4] SCHOLASTIC CORP Insider Trading Activity
Rhea-AI Filing Summary
Paul Hukkanen, Senior Vice President and Chief Accounting Officer of Scholastic Corporation (SCHL), reported a non-derivative acquisition on 09/23/2025 of 4,654 shares of Common Stock via a grant of restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant. The Form 4 shows a reported price of $25.78 and indicates 14,310 shares are beneficially owned following the transaction, held directly. The filing was signed on behalf of Mr. Hukkanen by an attorney-in-fact on 09/25/2025. The disclosure is a routine insider equity grant with a defined vesting schedule and no derivative transactions reported.
Positive
- Time-based restricted stock units granted with a clear vesting schedule (three equal annual installments) aligns officer incentives with long-term performance
- Beneficial ownership increased to 14,310 shares following the reported grant, showing greater direct alignment with shareholder outcomes
- No derivative transactions or dispositions reported, indicating this was a straightforward equity grant rather than a sale or hedging activity
Negative
- None.
Insights
Routine executive equity grant with standard multi-year vesting; aligns compensation with long-term retention.
The Form 4 reports a time-based restricted stock unit grant of 4,654 shares to the SVP and Chief Accounting Officer, with vesting in three equal annual installments starting one year after grant. This structure is typical for aligning senior officer incentives with company performance over multiple years. Beneficial ownership after the grant is 14,310 shares held directly. There are no sales, option exercises, or derivative positions disclosed, and the submission was authorized by an attorney-in-fact.
Insider increased direct holdings through equity compensation; transaction appears non-material to shareholders.
The reported acquisition of 4,654 shares at a reported price of $25.78 reflects a restricted stock unit grant rather than an open-market purchase. With total direct beneficial ownership at 14,310 shares post-grant, the transaction increases the officer's equity stake but represents a routine compensation event. No derivative securities, dispositions, or unusual terms are documented in the filing.